Few discoveries can completely transform an existing discipline, and clustered regularly interspaced short palindromic repeats (CRISPR) technology is one such breakthrough discoveries. It is not just a gene-editing tool, but a concept that allows scientists to manipulate cells like never before. With potential impact not just in the healthcare sector, the applications and the demand of the technology are set to expand exponentially.
CRISPR technology is undoubtedly one of the breakthrough discoveries in this era in genetic engineering. Originally discovered as an intrinsic component of prokaryotic defence against viruses, the CRISPR/Cas system has the prospect of becoming the leading technology in medical research, industrial biology, agriculture, and biofuel in the future. Based on the effector genes, the CRISPR/Cas system can be functionally classified into classes 1 and 2. Class 2 contains a single effector nuclease and finds the most extensive applications, and includes type II (such as CRISPR/Cas9 system), V, and VI CRISPR/Cas systems. Whereas, the class 1 CRISPR system consists of multiple subunits of effector nuclease complexes, and includes the type I, III, and IV CRISPR/Cas systems.
Owing to its precise gene-editing capability, CRISPR has accelerated research related to drug design to treat diseases such as HIV and cancer that have since long remained a challenge for conventional therapeutics. In agriculture, it has helped to improve crop yield, resistivity to diseases, pests, heat and droughts, and improving nutritional content. The technology also finds application in cattle breeding programs. It allows targeted mutations such as insertion, deletion, or regulation of gene expression to obtain desirable phenotypes, improved productivity and resistance to certain diseases. If researched extensively, CRISPR/Cas system has an unprecedented scope of DNA rewriting, and together with synthetic biology it can build complex and programmable gene circuits, and expand its current applications in therapeutics, diagnostics, and biotechnology.
The course will be launch to provide a comprehensive insight into the fundamental aspects of CRISPR technology and will aim to inform you about the emerging, cutting-edge research technologies and advanced tools used in biomedical research.
THE SCOPE OF CRISPR TECHNOLOGY
The rapid advancements and extensive research have expanded the horizon for applications of CRISPR technology. In addition, it has created a future-focused industry with increasing global market demands. Therefore, a well-trained and certified professional with knowledge to design research using CRISPR as one of the biomedical tools and interpret experimental findings has unprecedented scope for etching a successful career in this domain. Simultaneously, the advanced course would provide a competitive-edge to help professionals to stay ahead of their peers. With the successful completion of the advanced certified course, be prepared to embrace the vast opportunities that lie ahead.
This self-learning course aims to give learners a comprehensive knowledge of CRISPR technology and the latest advancements. The program is designed to provide in-depth information about the technology and on-going research activities in plants, animals and therapeutics, along with its evolution, ethical concerns, prospects, and challenges. Designed as an online course, it allows you to study from any remote location at your own convenient time without having to alter your set schedule. This is an advanced course with integrated advanced multimedia to make your experience more realistic and easy to understand and remember. In the end, the course offers a simplified self-assessment using a self-evaluation test to achieve a completion certificate for the course.
This advanced course is designed to be suitable for a wide range of professionals with appropriate backgrounds. Bioscience undergraduate or graduates and postgraduate scholars, researchers, academicians such as lecturers and professors, investor or venture capitalist, policymakers, and other industry professionals who are interested to understand the complexities in genome engineering, will find the course to be helpful. Those who have attended the first edition of ‘Genome Editing Using CRISPR’ course can also benefit from the additional and advanced-level information presented in this course. A background in bioscience is needed for understanding and undertaking self-learning in this field.
An Online Self Learning Certification Course is an online course that allows you to learn from anywhere at any time. You can learn this self-learning course at your own pace by logging in whenever you wish to!
Enrolling for this course is a very simplified process involving online enrolment. Once registered, you will receive a confirmation email immediately, containing all the details. We will then reach out again to you on the day of commencement of the course with details regarding access to course material.
This course is designed to be completed within six months. Failing to successfully complete the self-evaluation test would then require you to revise the course again within the course of the next six months to complete your certification. Your credential would expire if the course isn’t completed within this time frame.
This course relies on a system of self-evaluation for assessment of personal learning. Your certification course is complete with the successful passing of this self-evaluation test.
The CRISPR Genome Editing Program is envisioned and designed by a team of highly trained professionals with diverse interdisciplinary backgrounds. Combining our experience and hours of research, we have crafted the course with the aim to provide you an educational experience that would contribute towards your career success.
Students registering for our program will receive our complimentary eBook with title: The Revolution of The CRISPR-Cas9 System.
GET IN TOUCH
Need more information? Get in touch with our team. Our friendly and responsive customer service staff will respond to your query soon as possible.